ClinicalTrials.gg
RecruitingNCT07535047TENS in LBPUpdated Apr 16, 2026

Placebo-Induced Hypoalgesia During Transcutaneous Electrical Nerve Stimulation Application in Low Back Pain

An interventional study of TENS and TENS educational explanation video in Low Back Pain (LBP) and Low Back Pain, sponsored by Cairo University. Recruiting at 1 site in Egypt. Open to participants aged 18 Years to 65 Years. Per ClinicalTrials.gov, last updated 2026-04-16.

Sponsored by Cairo University · Not applicable, Interventional, and Treatment

How we know

From the registry’s dates

  • Primary completion was expected by Aug 2026, 3 months ago, but the record still lists the study as recruiting.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
40
Allocation
Randomized
Ages
18 Years to 65 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 74 studies in Low Back Pain by Cairo University — 33 open to participants now, 33 under way, none of them phase 3. Low Back Pain · Cairo University.

Planned enrollment
51st of 65
40 · median 60
Started
2026
with 8 others
No phase
65 of 74
29 open now
Primary completion
2026-08
later than 25 of 32 live
Registered
66th of 74
by date

Among the 74 studies in Low Back Pain by Cairo University, this one is the 51st largest by planned enrollment of the 65 interventional ones that give a count, is one of 9 that started in 2026, is one of 65 with no phase, reaches primary completion later than 25 of the 32 other live ones, and was the 66th registered.

Low Back Pain

2,930 studies on the registry are indexed under Low Back Pain; 581 are open to participants now.

Browse Low Back Pain studies →

Open to participants now

33 of the 74 studies in Low Back Pain by Cairo University are open now, in 2 countries. Recruiting first, the newest first:

27 more — sign in →

By country, each count listing its studies:

All 33 open studies →

Where they have run

Who these studies take

Of the 332 Low Back Pain studies recruiting now, 93 (28%) set no upper age limit and 209 (63%) stop at 75 or younger; 8 take children under 18; 46 take healthy volunteers.

This study: 18 Years to 65 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 74 studies in Low Back Pain by Cairo University, or all of them as a file.
02

Study summary

The primary goal of this clinical trial is to evaluate the feasibility of conducting a full-scale randomized controlled trial (RCT), considering recruitment, compliance with study protocols, and adverse events. The secondary goal is to evaluate the effectiveness of a video-based educational explanation of transcutaneous electrical nerve stimulation (TENS) in eliciting placebo-induced hypoalgesia and improving clinical outcomes in patients with acute low back pain.

The main question it aims to answer is: Does the addition of a video-based educational explanation of TENS to standard physical therapy rehabilitation, consisting of TENS and exercises, increase the pressure pain threshold, reduce pain intensity, and improve functional mobility, patient satisfaction, and quality of life in patients with acute low back pain?

Participants will be divided into two groups for comparison: the control group will receive standard physical therapy rehabilitation consisting of TENS and exercises, while the experimental group will receive the same program in addition to the video-based educational explanation of TENS.

Read the detailed description

Pain modulation through expectation is a well-established phenomenon. Anticipating relief from a treatment can enhance the effects of both pharmacological and non-pharmacological analgesic interventions. The expectation of pain relief can reduce the perceived intensity of stimuli and is associated with changes in brain regions involved in pain processing, including the thalamus, prefrontal cortex, and somatosensory cortices. Previous research suggests that expectation can have a moderate to large effect on experimental and acute procedural pain.

Based on this, the investigators hypothesize that adding a video-based educational explanation of TENS to a standard physical therapy rehabilitation program will enhance patient expectations regarding the intervention. This may elicit placebo-induced hypoalgesia and improve clinical outcomes in patients with acute low back pain.

03

Conditions studied

  • Low Back Pain (LBP)
  • Low Back Pain

Browse trials for

Keywords

  • TENS
  • Transcutaneous Electrical Nerve Stimulation
  • Placebo
  • Hypolagesia
04

Who can participate

Ages eligible
18 Years to 65 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • acute low back pain without radicular pain to lower limbs
  • minimal pain level of 4 on the 0-10 VAS
  • 18-65 years of age
  • TENS naïve or have not used TENS in the past 5 years.

Exclusion criteria

Exclusion Criteria:

  • Radicular pain to lower limbs
  • Serious spinal disorders, such as fractures, tumors, or inflammatory arthritis disease
  • Nerve root disorders confirmed by neurological tests
  • Neurological diseases
  • Severe cardiorespiratory disease
  • Pregnancy
  • Skin infection or lesions or change in sensation at the TENS application site
  • Cancer
  • Cardiac pacemaker
  • Allergy to electrodes
  • use of opioids.
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Investigator, Outcomes assessor)
Enrollment
40 participants (estimated)

Study arms

  • Experimental
    Experimental: TENS + Educational Video + Exercise Program

    Participants in this group will receive transcutaneous electrical nerve stimulation (TENS) along with a structured home exercise program and will also view an educational video explaining TENS.

    Device: TENS · Behavioral: TENS educational explanation video · Other: Exercise

  • Active comparator
    Active Comparator: TENS + Exercise Program

    Participants in this group will receive transcutaneous electrical nerve stimulation (TENS) along with a structured home exercise program.

    Device: TENS · Other: Exercise

Interventions

  • DeviceTENS

    12 sessions of TENS each lasting 45 minutes ,will be conducted over a 4-week intervention period .

    Also known as: Transcutaneous Electrical Nerve Stimulation

  • BehavioralTENS educational explanation video

    The video provides standardized information on TENS, demonstrating its use, safety, and how it modulates pain through gate control theory

  • OtherExercise

    Participants will be provided with a home program consisting of exercises targeting trunk core activation, spinal mobility, and functional movement, as approved by the American Physical Therapy Association (APTA).

06

What researchers measure

Primary outcomes

  1. Feasibility assessed using a structured feasibility questionnaire

    Feasibility will be evaluated using a structured questionnaire designed to assess the practicality of conducting a future randomized controlled trial (RCT), including aspects such as recruitment, adherence, and data collection. Responses will be summarized descriptively.

    Time frame: Baseline (Day 1) and 4 weeks post-treatment.

  2. Success rate of obtaining consent from those eligible participants

    Number of participants enrolled/randomised

    Time frame: During the enrolment process

  3. Retention rate of the participants

    Retention rate is defined as proportion of people that finished the programme after 4 weeks. Retention data will be assessed based on (i) proportion of participants with complete outcome assessment; (ii) number of discontinuation and reasons.

    Time frame: Recorded at week 4 at the end of delivering the intervention.

  4. Adherence of the participants

    Adherence is defined as the number and proportion of scheduled sessions undertaken by the participants.

    Time frame: Recorded at week 4 at the end of delivering the intervention.

Secondary outcomes

  1. Pressure Pain Threshold measured using a pressure algometer

    Pressure Algometer Device used to assess pain threshold with scores measured with kg/cm², with higher scores indicating greater tolerance to pressure-induced pain.

    Time frame: Baseline (Day 1), 4 weeks post-treatment, and 3 months follow-up.

  2. Pain intensity measured using the Visual Analogue Scale (VAS)

    A Single-item pain scale to assess pain intensity at rest and during movement before and after intervention (at 3 time points).Scores range from 0 (no pain) to 10 (maximum pain).Higher scores indicate greater pain intensity.

    Time frame: Baseline (Day 1), 4 weeks post-treatment, and 3 months follow-up.

  3. Functional disability measured using the Oswestry Disability Index (ODI)

    Functional disability related to low back pain was assessed using the Oswestry Disability Index (ODI), a self-reported questionnaire scored from 0 to 100. Higher scores indicate greater disability, with 0 representing no disability and 100 representing maximum disability.

    Time frame: Baseline (Day 1), 4 weeks post-treatment, and 3 months follow-up.

  4. Participant satisfaction measured using the Visual Analogue Scale (VAS)

    Participant satisfaction will be assessed using a Visual Analogue Scale (VAS). Scores range from 0 (not satisfied at all) to 10 (completely satisfied), with higher scores indicating greater satisfaction with the intervention.

    Time frame: Baseline (Day 1), 4 weeks post-treatment, and 3 months follow-up.

  5. Health-related quality of life measured using the 36-Item Short Form Survey (SF-36)

    Health-related quality of life was assessed using the 36-Item Short Form Survey (SF-36), which evaluates eight domains: physical functioning, role physical, bodily pain, general health, vitality, social functioning, role emotional, and mental health. Each domain is scored from 0 to 100, with higher scores indicating better health status and functioning.

    Time frame: Baseline (Day 1), 4 weeks post-treatment, and 3 months follow-up.

07

Study locations

1 of 1 sites recruiting
08

References and documents

Publications

  • Zaworski K, Baj-Korpak J, Tokarska-Rodak M, Plazuk E, Dyrda A, Bialosky J, Rossettini G. Can pre-treatment verbal suggestions influence the short-term effects of spinal manipulation in young adults with chronic non-specific low back pain? A randomized controlled trial. Musculoskelet Sci Pract. 2025 Nov;80:103431. doi: 10.1016/j.msksp.2025.103431. Epub 2025 Oct 10. PubMed 41106172 ↗
  • Meeuwis SH, Wasylewski MT, Bajcar EA, Bieniek H, Adamczyk WM, Honcharova S, Di Nardo M, Mazzoni G, Babel P. Learning pain from others: a systematic review and meta-analysis of studies on placebo hypoalgesia and nocebo hyperalgesia induced by observational learning. Pain. 2023 Nov 1;164(11):2383-2396. doi: 10.1097/j.pain.0000000000002943. Epub 2023 Jun 15. PubMed 37326688 ↗
  • Ruzic V, Ivanec D, Stanke KM. Effect of expectation on pain assessment of lower- and higher-intensity stimuli. Scand J Pain. 2017 Jan;14:9-14. doi: 10.1016/j.sjpain.2016.09.013. Epub 2016 Oct 27. PubMed 28850443 ↗
  • Peerdeman KJ, van Laarhoven AIM, Keij SM, Vase L, Rovers MM, Peters ML, Evers AWM. Relieving patients' pain with expectation interventions: a meta-analysis. Pain. 2016 Jun;157(6):1179-1191. doi: 10.1097/j.pain.0000000000000540. PubMed 26945235 ↗

Individual participant data

Plan to share: No

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Start is estimated for Apr 2026; primary completion for Aug 2026, 4 months later.

Of 1,234 non-industry interventional studies with no phase under Low Back Pain, half reached primary completion within 11 months of starting (the median), counting those still running; a quarter within 4 and three quarters within 26. This study's planned 4 months is below that.

Counting every sponsor, half of 1,290 studies reached it within 11 months; a quarter within 5 and three quarters within 27.

How these figures are worked out, and which studies are left out of them.

Registered
Apr 2, 2026
First posted
Apr 16, 2026
StartEst.
Apr 5, 2026
Primary completionEst.
Aug 20, 2026
CompletionEst.
Sep 1, 2026
Last update
Apr 16, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Apr 16, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07535047
Lead sponsor
Cairo University
Responsible party
Ahmed ElMelhat (Associate Professor of MSK Physical Therapy, BAU and Cairo university, Cairo University) — Principal investigator
First posted
Apr 16, 2026
Start date
Apr 5, 2026 (estimated)
Primary completion
Aug 20, 2026 (estimated)
Completion
Sep 1, 2026 (estimated)
Last update
Apr 16, 2026

Study contacts

Ahmed El Melhat, PhD
Contact
ahmed.elmelhat@cu.edu.lb
+20 11 12595022
Sara Ahmad Manasfi, BSc
Contact
sarahms611998@gmail.com
+961 76806944
Ahmed El Melhat, PhD
study director · Cairo University

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion